Improve mobility with rotational exercises

Trial ID
NCT07442370
Official Title
The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease Patients: A Randomized Controlled Study
Goal
Improve mobility with rotational exercises
Phase
NA
Status
RECRUITING
Sponsor
Uskudar University
Study Type
INTERVENTIONAL
Enrollment
50 participants
Conditions
Parkinson Disease, Parkinsonism
Interventions
conventional physiotherapy, conventional physiotherapy + exercise

Summary For Families

The goal is to find out whether adding specific functional rotational exercises to regular physiotherapy can reduce fall risk and improve mobility and turning ability in people with mild Parkinson's. The approach adds guided trunk and limb rotation drills to conventional physiotherapy, aiming to boost core strength, trunk mobility, weight shifting, and balance reactions so people can turn and recover from slips more safely. The trial is looking for volunteers aged 50 to 70 with idiopathic Parkinson's at Hoehn and Yahr stages 1 to 2, with stable medications and cognition (MMSE ≥ 24), and it excludes advanced PD, major orthopedic or vestibular problems, or serious falls in the past six months.

Locations

  • Sancak Medical Center, Istanbul, Sancaktepe, Turkey (Türkiye)

Frequently Asked Questions

What is this trial testing?
This trial is studying conventional physiotherapy. The goal is to find out whether adding specific functional rotational exercises to regular physiotherapy can reduce fall risk and improve mobility and turning ability in people with mild Parkinson's. The approach adds guided trunk and limb rotation drills to conventional physiotherapy, aiming to boost core strength, trunk mobility, weight shifting, and balance reactions so people can turn and recover from slips more safely. The trial is looking for volunteers aged 50 to 70 with idiopathic Parkinson's at Hoehn and Yahr stages 1 to 2, with stable medications and cognition (MMSE ≥ 24), and it excludes advanced PD, major orthopedic or vestibular problems, or serious falls in the past six months.
Who can participate?
Participants must be between 50 Years and 70 Years.
Where is this trial located?
This trial is recruiting at 1 location.
Does it cost anything to join?
No. There is no cost to participate. Study-related care and treatment are provided at no charge.
How long does the trial last?
This trial is estimated to last approximately 4 months.
Will I get the real drug or a placebo?
It depends on the trial design. Some Parkinson's trials are placebo controlled, meaning a portion of participants get an inactive comparison while others get the experimental treatment. Some use crossover designs so everyone eventually receives the active treatment at some point. Observational trials do not use a placebo at all because they are not testing a new treatment. The consent form for any specific trial spells out the design and your odds of being assigned to placebo before you enroll.
How often will I need to visit the study site?
Visit frequency varies by trial. Many Parkinson's studies require an in person visit every 4 to 12 weeks during the active treatment phase, with shorter or longer gaps depending on the design. The site coordinator can give you the full visit schedule before you sign anything, so you know what the time commitment looks like.
Can I leave the trial if I change my mind?
Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
Will travel or parking be reimbursed?
Many trials reimburse for parking, mileage, and sometimes lodging if the site is far from your home. Reimbursement policies vary by sponsor and site. When you contact the trial team, ask specifically what is covered and how reimbursement is processed.
Can my spouse or care partner come with me to visits?
In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.

Related Reading

View on ClinicalTrials.gov